移植市場の市場規模、シェア、成長分析：製品タイプ別、用途別、最終用途別、地域別 - 産業予測 2025～2032年

移植の世界市場規模は2023年に154億7,000万米ドルと評価され、予測期間（2025-2032年）のCAGRは8.9%で、2024年の168億5,000万米ドルから2032年には333億2,000万米ドルに成長する見通しです。

世界の移植市場は、高齢化とライフスタイルの変化による臓器不全や慢性疾患の罹患率の上昇を主な要因として、大きな成長が見込まれています。手術技術の向上、免疫抑制療法の進歩、組織工学の革新により、移植の成功率は著しく向上し、需要を押し上げています。しかし、この分野は、移植手術の複雑さ、専門的なケアの必要性、移植前後のケアにかかる高額な費用に伴う経済的負担などの課題に直面しています。こうしたハードルにもかかわらず、臓器保存のための機械灌流や免疫抑制剤の改良開発など、技術による市場開発の可能性は残されています。臓器不足に対処し、移植サービスを拡大し、最終的に患者の転帰を向上させるためには、臓器提供を促進するための意識の向上と政府の協力的な取り組みが不可欠です。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 規制情勢

移植市場規模：製品タイプ別& CAGR（2025-2032）

• 市場概要
• 組織製品
• 免疫抑制薬
• 保存ソリューション

移植市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 臓器移植
• 組織移植

移植市場規模：最終用途別& CAGR（2025-2032）

• 市場概要
• 病院
• 移植センター
• その他

移植市場規模& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• AbbVie Inc.（USA）
• BioLife Solutions（USA）
• Medtronic（USA）
• Arthrex, Inc.（USA）
• Zimmer Biomet（USA）
• 21st Century Medicine（USA）
• Novartis AG（Switzerland）
• Stryker（USA）
• Teva Pharmaceutical Industries Ltd.（Israel）
• Veloxis Pharmaceuticals, Inc.（USA）
• TransMedics Inc.（USA）
• Hoffmann-La Roche Ltd.（Switzerland）
• Astellas Pharma Inc.（Japan）
• Preservation Solutions, Inc.（USA）
• OrganOx Limited（UK）
• Terumo Corporation（Japan）
• Transonic（USA）
• Sanofi（France）
• Pfizer Inc.（USA）
• CareDx, Inc.（USA）

結論と提言

Global Transplantation Market size was valued at USD 15.47 billion in 2023 and is poised to grow from USD 16.85 billion in 2024 to USD 33.32 billion by 2032, growing at a CAGR of 8.9% during the forecast period (2025-2032).

The global transplantation market is poised for significant growth, driven primarily by the rising incidence of organ failure and chronic diseases, fueled by aging populations and lifestyle changes. Enhanced surgical techniques, advanced immunosuppressive therapies, and innovations in tissue engineering have markedly improved transplant success rates, boosting demand. However, the sector faces challenges, including the complexity of transplant procedures, specialized care requirements, and the financial burden associated with high costs of pre- and post-transplant care. Despite these hurdles, the market holds potential for advancement through technology, such as machine perfusion for organ preservation and the development of improved immunosuppressive drugs. Increased awareness and collaborative government efforts to promote organ donation are essential to address shortages and expand transplantation services, ultimately enhancing patient outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Transplantation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Transplantation Market Segments Analysis

Global Transplantation Market is segmented by Product Type, Application, End-Use and region. Based on Product Type, the market is segmented into Tissue Products, Immunosuppressive Drugs and Preservation Solutions. Based on Application, the market is segmented into Organ Transplantation and Tissue Transplantation. Based on End-Use, the market is segmented into Hospitals, Transplant Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Transplantation Market

The increasing prevalence of chronic diseases, including end-stage renal failure, liver cirrhosis, heart failure, and respiratory ailments, is driving significant growth in the global transplantation market. Specifically, the surge in diabetes cases and its associated complications has intensified the need for kidney and pancreas transplants. As more individuals require these vital organ transplants to improve their quality of life and overcome debilitating health conditions, the demand for transplantation services continues to rise. This trend highlights the critical role that healthcare providers and organizations play in addressing the urgent need for organ donations and transplantation solutions worldwide.

Restraints in the Global Transplantation Market

The global transplantation market faces several constraints primarily due to the high costs associated with organ transplantation. Expenses encompass pre-transplant evaluations, surgical procedures, post-operative care, and ongoing immunosuppressive medication, creating substantial financial strains for patients, healthcare systems, and insurance providers alike. Additionally, inadequate insurance coverage and restrictive reimbursement policies surrounding transplant-related services further diminish the affordability and accessibility of these essential procedures. As a result, many individuals may struggle to receive necessary transplants, which can significantly hinder the overall growth and development of the transplantation market on a worldwide scale.

Market Trends of the Global Transplantation Market

The global transplantation market is witnessing a notable trend towards precision medicine, reflecting a heightened emphasis on personalized transplant therapies. This approach leverages individual genetic profiles, immunological compatibility, and specific disease characteristics to enhance treatment efficacy. The incorporation of advanced diagnostics and biomarkers facilitates tailored immunosuppressive strategies, leading to improved patient outcomes and reduced complications. As healthcare providers increasingly utilize genetic testing, the demand for customized transplant protocols is expected to rise, driving innovation and fueling market growth. This shift towards precision medicine underscores the commitment to optimize transplantation success rates and enhance quality of life for patients worldwide.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape

Global Transplantation Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Tissue Products
• Immunosuppressive Drugs
• Preservation Solutions

Global Transplantation Market Size by Application & CAGR (2025-2032)

• Market Overview
• Organ Transplantation
• Tissue Transplantation

Global Transplantation Market Size by End-Use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Transplant Centers
• Others

Global Transplantation Market Size & CAGR (2025-2032)

• North America (Product Type, Application, End-Use)
  • US
  • Canada
• Europe (Product Type, Application, End-Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, End-Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, End-Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, End-Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• AbbVie Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioLife Solutions (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arthrex, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 21st Century Medicine (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Veloxis Pharmaceuticals, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TransMedics Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Astellas Pharma Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Preservation Solutions, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OrganOx Limited (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Transonic (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CareDx, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations